Blog - Page 2 of 5699 - QualityStocks

WednesdayJul 29, 2026 10:30 am

QualityStocksNewsBreaks – Datavault AI Inc. (NASDAQ: DVLT) Expands DataMEDS Licensing Agreement Into Commercial Healthcare

Datavault AI (NASDAQ: DVLT) expanded its definitive licensing agreement with DataMeds AI Inc. (NASDAQ: MEDS) to extend its PharmacyChain blockchain-related technology beyond pharmaceutical distribution into commercial healthcare, healthspan and wellness applications. The expanded relationship is designed to support patient-controlled health data access, monetization and real-world asset tokenization across pharmacy, medical, laboratory and wearable device environments, leveraging a behavioral healthcare patent portfolio focused on medical logistics, IoT population health and AI-driven remote patient monitoring. Under the amended agreement, Datavault AI will receive common shares representing approximately 19.9% of DataMEDS' outstanding common stock upon closing of previously announced related transactions, replacing the…

WednesdayJul 29, 2026 9:45 am

VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform

The company has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer. The leadership change comes as the company advances its proprietary BiTAC(R) technology platform toward clinical development. VERAXA is building a diversified oncology pipeline that includes conditionally active T-cell engagers, bispecific ADCs and other engineered antibody therapeutics. Recent regulatory feedback from Germany's Paul-Ehrlich-Institute has provided additional clarity for development of the company's lead BiTAC(R)-TCE program. Investors are watching companies developing next-generation immunotherapies that seek to improve efficacy while reducing treatment-related toxicity. VERAXA Biotech (NASDAQ: VRXA), an emerging leader in designing novel cancer therapies, has appointed antibody therapeutics…

WednesdayJul 29, 2026 9:20 am

QualityStocksNewsBreaks – Streamex Corp. (NASDAQ: STEX) Highlights Tokenization Platform Strategy in Investor Video

Streamex (NASDAQ: STEX) released an investor video featuring Vice President of Product and Design Kori Handy, outlining the company's long-term strategy to build a tokenized commodity infrastructure extending well beyond gold. The presentation emphasizes that while GLDY serves as the company's initial asset, the underlying custody, compliance, liquidity, banking and distribution infrastructure is designed to support future tokenized commodities including silver, oil and gas, and copper. Streamex also highlighted partnerships with Siebert Financial, Inspira Financial, Equity Trust, tZERO, Wintermute, Coinbase Prime, Anchorage Digital and BitGo as components of its expanding distribution and trading ecosystem. The company said its roadmap includes…

WednesdayJul 29, 2026 9:00 am

American Fusion(TM) Inc. (AMFN) Expands Commercial Leadership as Texatron(TM) Development Advances Through Testing, Regulatory and Patent Milestones

The company has appointed Alec Rossa as Chief Revenue Officer to lead commercialization, strategic partnerships, and deployment of the company's planned Power-as-a-Service (“PaaS”) business model. Management says early commercial opportunities include AI data centers, industrial facilities, defense applications and other energy-intensive infrastructure. The company is pursuing a strategy that combines technology development, intellectual property protection and recurring revenue through long-term Power-as-a-Service agreements. American Fusion(TM) recently highlighted progress on its Texas Tech University testing program, following regulatory authorization covering all twelve Texatron(TM) Fusion Engine(TM) research systems. American Fusion(TM) has also expanded its intellectual property portfolio to 76 U.S. patent applications, moving…

WednesdayJul 29, 2026 9:00 am

QualityStocksNewsBreaks – VERAXA Biotech AG (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms

VERAXA Biotech (NASDAQ: VRXA) announced an expansion of its intellectual property portfolio, filing new patent applications during the first half of 2026 covering its next-generation BiTAC-TCE and BiTAC-ADC technology platforms and related therapeutic programs. The company said previously granted patents protecting supporting technologies have also cleared the opposition period, bringing its portfolio to more than 50 granted owned or exclusively licensed patents across 14 countries and 26 patent families. Pending approval of the latest filings, VERAXA expects its core technologies to be protected through at least 2047. The company said its BiTAC platform is designed to improve the selectivity and…

TuesdayJul 28, 2026 2:18 pm

QualityStocksNewsBreaks – Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) Advances Portfolio Amid Growing Demand for Critical Minerals

Disseminated on behalf of Powermax Minerals Inc. (CSE: PMAX) (OTCQB: PWMXF) and may include paid advertising. Powermax Minerals (CSE: PMAX) (OTCQB: PWMXF) has begun helicopter-borne geophysical surveys and field exploration at its Pinard and Hopkins rare earth element properties in Ontario. The program combines magnetic, radiometric and VLF-EM surveys with geological mapping, prospecting and surface sampling to improve geological understanding and help identify areas for potential follow-up exploration and drilling. While the airborne data has not yet been processed or interpreted, the company expects to integrate the results with field exploration findings to refine future exploration priorities. The work advances Powermax’s broader rare earth portfolio…

TuesdayJul 28, 2026 1:46 pm

QualityStocksNewsBreaks – SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) Advances GPS-Free Drone Intelligence as Electronic Warfare Evolves

Disseminated on behalf of SPARC AI Inc. (CSE: SPAI) (OTCQB: SPAIF) and may include paid advertising. SPARC AI (CSE: SPAI) (OTCQB: SPAIF) was featured in an article that explores the growing defense need for technologies that can operate without GPS as increasingly sophisticated jamming and spoofing expose vulnerabilities in satellite-based navigation. As drones and autonomous systems become more dependent on GPS, defense organizations are seeking resilient, software-based navigation, targeting, and intelligence solutions that can be deployed across existing platforms. SPARC AI is positioned in this emerging market through its Overwatch platform, which uses AI and software to provide GPS-free target acquisition and intelligence…

TuesdayJul 28, 2026 11:20 am

QualityStocksNewsBreaks – Greenland Mines Ltd. (NASDAQ: GRML) Secures Canadian Patent for Klotho Gene Therapy Technology

Greenland Mines (NASDAQ: GRML) announced that Innovation, Science and Economic Development Canada has granted a patent covering technology exclusively licensed by the company for Klotho-based gene therapies targeting cognition, memory and neurodegenerative diseases. The patent protects the use of the secreted Klotho ("s-KL") RNA splice variant in genetic therapies and includes 42 claims covering its synthesis, delivery methods and potential application across multiple neurological disorders, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis ("ALS") and multiple sclerosis. The company said the Canadian patent expands its intellectual property portfolio for Klotho-based therapeutics and complements previously issued patents in the United States, China and Europe. Greenland Mines added that…

TuesdayJul 28, 2026 11:15 am

Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial and Regulatory Momentum as GelrinC Advances Toward Key Clinical and Regulatory Milestones

Regentis is advancing GelrinC through a pivotal stage of development, with key catalysts including U.S. clinical study enrollment, European commercialization activities, and continued manufacturing optimization. Strategic interest in cartilage regeneration technologies was highlighted by Smith+Nephew’s acquisition of CartiHeal for up to $330 million, underscoring the potential value of innovative orthopedic solutions designed to address unmet needs in cartilage repair. GelrinC is an off-the-shelf, cell-free, one-step hydrogel-based implant designed to simplify cartilage repair through a procedure that supports and mimics the body's natural regenerative processes. Cartilage Regeneration Gains Strategic Validation The orthopedic industry is increasingly focused on technologies that can address…

TuesdayJul 28, 2026 10:55 am

QualityStocksNewsBreaks – MindWave Innovations Inc. (NYSE American: APUS) Launches MindChain, Announces U.S. Listing for NILA Token

MindWave Innovations (NYSE American: APUS), a wholly owned subsidiary of Apimeds Pharmaceuticals, announced MindChain, which it describes as the world's first fully insured blockchain. The Ethereum Virtual Machine-compatible Layer 2 network is scheduled to launch in October 2026 and is designed to provide Ethereum-backed settlement while supporting faster transactions, staking, cross-chain asset transfers and industry-specific subnetworks. The company also announced that its NILA token will become available to U.S. users on the Webot cryptocurrency exchange beginning Aug. 3, ahead of its planned migration to MindChain as the network's native token. The company said MindChain will provide the MindWaveDAO ecosystem with its own dedicated blockchain infrastructure, enabling predictable transaction costs and supporting applications across sectors…

Site Search

Company Search